scholarly journals Systematic Review and Meta-Analysis of Diabetes Knowledge among Type 2 Diabetes Patients in Southeast Asia

2021 ◽  
Vol 17 (2) ◽  
pp. 82-89
Author(s):  
Phei Ching Lim ◽  
Retha Rajah ◽  
Chong Yew Lee ◽  
Te Ying Wong ◽  
Sherene Su Ann Tan ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Glycemic Control ◽  
Southeast Asia ◽  
English Language ◽  
Meta Analysis ◽  
Knowledge Score ◽  
Assessment Tools ◽  
Current Evidence ◽  
Diabetes Knowledge

OBJECTIVE: Recognition of patient baseline knowledge is important in educating patients with type 2 diabetes mellitus (T2D) to manage their disease effectively. The purpose of this study is to review current evidence on the level of diabetes knowledge among T2D patients and determine factors affecting their knowledge. METHODS: A systematic search of English language articles published between 1990 and June 2019 was conducted using six electronic databases. Only quantitative studies that assessed knowledge of T2D patients in Southeast Asian countries were included. Data were extracted and a meta-analysis was conducted. RESULTS: A total of 6210 articles were retrieved; seven articles met the inclusion criteria, comprising 1,749 T2D patients. The calculated mean knowledge score was 55.6% (95% CI: 7.6 to 103.6). Five types of assessment tools were identified ranging from five to 41 questions that focused on disease specifics, treatment, and nutrition. Age, education level, and glycemic control were the most common factors impacting knowledge. CONCLUSIONS: The level of knowledge among T2D patients in Southeast Asia was unsatisfactory, especially in older patients with low education levels and poor glycemic control. Hence, an appropriate educational plan should be prioritized to these groups.

scholarly journals Self-Management Education for Adults With Type 2 Diabetes: A meta-analysis of the effect on glycemic control

Diabetes Care ◽  
2002 ◽  
Vol 25 (7) ◽  
pp. 1159-1171 ◽  
Author(s):  
S. L. Norris ◽  
J. Lau ◽  
S. J. Smith ◽  
C. H. Schmid ◽  
M. M. Engelgau
Keyword(s):  
Type 2 Diabetes ◽  
Glycemic Control ◽  
Management Education ◽  
Meta Analysis ◽  
Self Management

scholarly journals TheType 2 Deiodinase Thr92Ala PolymorphismIs Associated with Worse Glycemic Control in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis

2016 ◽  
Vol 2016 ◽  
pp. 1-6 ◽  
Author(s):  
Xiaowen Zhang ◽  
Jie Sun ◽  
Wenqing Han ◽  
Yaqiu Jiang ◽  
Shiqiao Peng ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Systematic Review ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Glycemic Control ◽  
Meta Analysis ◽  
Increased Risk ◽  
Design And Methods ◽  
Hba1c Levels

Objective. Type 2 deiodinase (Dio2) is an enzyme responsible for the conversion of T4 to T3. The Thr92Ala polymorphism has been shown related to an increased risk for developing type 2 diabetes mellitus (T2DM). The aim of this study is to assess the association between this polymorphism and glycemic control in T2DM patients as marked by the HbA1C levels.Design and Methods.The terms “rs225014,” “thr92ala,” “T92A,” or “dio2 a/g” were used to search for eligible studies in the PubMed, Embase, and Cochrane databases and Google Scholar. A systematic review and meta-analysis of studies including both polymorphism testing and glycated hemoglobin (HbA1C) assays were performed.Results. Four studies were selected, totaling 2190 subjects. The pooled mean difference of the studies was 0.48% (95% CI, 0.18–0.77%), indicating that type 2 diabetics homozygous for the Dio2 Thr92Ala polymorphism had higher HbA1C levels.Conclusions. Homozygosity for the Dio2 Thr92Ala polymorphism is associated with higher HbA1C levels in T2DM patients. To confirm this conclusion, more studies of larger populations are needed.

scholarly journals Diabetes knowledge and glycemic control among patients with type 2 diabetes in Bangladesh

SpringerPlus ◽  
2015 ◽  
Vol 4 (1) ◽  
Author(s):  
Sheikh Mohammed Shariful Islam ◽  
Louis W Niessen ◽  
Jochen Seissler ◽  
Uta Ferrari ◽  
Tuhin Biswas ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Glycemic Control ◽  
Diabetes Knowledge

scholarly journals Oral hypoglycaemic agents, insulin resistance and cardiovascular disease in patients with type 2 diabetes

2009 ◽  
Vol 161 (1) ◽  
pp. 1-9 ◽  
Author(s):  
Bianca Hemmingsen ◽  
Søren S Lund ◽  
Jørn Wetterslev ◽  
Allan Vaag
Keyword(s):  
Type 2 Diabetes ◽  
Cardiovascular Disease ◽  
Meta Analysis ◽  
Current Evidence ◽  
Cvd Risk ◽  
Oral Hypoglycaemic Agents ◽  
Increase Insulin Sensitivity ◽  
Hypoglycaemic Agents ◽  
Conflicting Evidence

This article is a narrative review of the current evidence of the effects on cardiovascular disease (CVD) of oral hypoglycaemic agents that increase insulin sensitivity in patients with type 2 diabetes (T2D). In overweight T2D patients, metformin has been demonstrated to reduce CVD risk, and this beneficial effect may be conserved with the combination of metformin and insulin treatment. However, the effect of glitazones on CVD is uncertain. There is conflicting evidence from large randomized trials to support a protective effect against CVD of lowering blood glucose per se but a systematic review with meta-analysis is lacking. It may be reasonable to aim for an intervention targeting multiple CVD risk factors such as dyslipidaemia, hypertension and albuminuria in T2D patients.

Sign in / Sign up

Export Citation Format

Share Document